Vaxcyte
PCVX
PCVX
265 hedge funds and large institutions have $9.26B invested in Vaxcyte in 2024 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 116 increasing their positions, 78 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
14% more capital invested
Capital invested by funds: $8.13B → $9.26B (+$1.13B)
6% more funds holding
Funds holding: 250 → 265 (+15)
2.79% more ownership
Funds ownership: 109.87% → 112.66% (+2.8%)
Holders
265
Holding in Top 10
15
Calls
$20.6M
Puts
$9.3M
Top Buyers
| 1 | +$81.3M | |
| 2 | +$32M | |
| 3 | +$30.3M | |
| 4 |
BlackRock
New York
|
+$29.1M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$28.5M |
Top Sellers
| 1 | -$45.6M | |
| 2 | -$41.7M | |
| 3 | -$27.5M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$22.4M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$22.2M |